Decitabine (Dacogen) for myelodysplastic syndromes.
D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D000077209:Decitabine; D001374:Azacitidine